ABSTRACT
Acrylic hydrogels: Dermalive1, Dermadeep1 (Dermatech). These products-EC labeled in 1999-are no longer on the European market and were never approved in the United States. Three to 10 years after the injections, it is still possible to see new cases of inflammatory, chronic, purple, inesthetic, and invalidating granulomas which have led to the prohibition of the product.
